Cargando…
Tumor microenvironment disparity in multiple primary lung cancers: Impact of non-intrinsic factors, histological subtypes, and genetic aberrations
INTRODUCTION: Multiple primary lung cancers (MPLCs) occur in common carcinogenetic risks such as lifestyle, biological aging, immune responses, hormones, and metabolism. Although MPLCs harbor various genetic profiles within the same individuals, differences in the tumor microenvironment (TME) are un...
Autores principales: | Izumi, Motohiro, Sawa, Kenji, Oyanagi, Jun, Noura, Ikue, Fukui, Mitsuru, Ogawa, Koichi, Matsumoto, Yoshiya, Tani, Yoko, Suzumura, Tomohiro, Watanabe, Tetsuya, Kaneda, Hiroyasu, Mitsuoka, Shigeki, Asai, Kazuhisa, Nishiyama, Noritoshi, Ohsawa, Masahiko, Yamamoto, Nobuyuki, Koh, Yasuhiro, Kawaguchi, Tomoya |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Neoplasia Press
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8102176/ https://www.ncbi.nlm.nih.gov/pubmed/33930847 http://dx.doi.org/10.1016/j.tranon.2021.101102 |
Ejemplares similares
-
Mutational landscape of multiple primary lung cancers and its correlation with non-intrinsic risk factors
por: Izumi, Motohiro, et al.
Publicado: (2021) -
Impact of tumor microenvironment on the efficacy of epidermal growth factor receptor‐tyrosine kinase inhibitors in patients with EGFR‐mutant non‐small cell lung cancer
por: Matsumoto, Yoshiya, et al.
Publicado: (2019) -
Differences in molecular epidemiology of lung cancer among ethnicities (Asian vs. Caucasian)
por: Izumi, Motohiro, et al.
Publicado: (2020) -
Vascular endothelial growth factor receptor 2 expression and immunotherapy efficacy in non–small cell lung cancer
por: Nakahama, Kenji, et al.
Publicado: (2022) -
Safe Concurrent Use of Anti-tuberculosis Drugs and Pembrolizumab in a Patient with Non-small-cell Lung Cancer Who Was Infected with Mycobacterium tuberculosis
por: Nakahama, Kenji, et al.
Publicado: (2022)